Recent Updates
Recently added Catalysts
MYO Positive Sentiment

MYOMO, INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

Key Takeaway: Myomo, Inc. has announced its intention to conduct an underwritten public offering of common stock. The offering aims to raise capital to support its wearable medical robotics for individuals with neurological disorders. The company may also grant the underwriter a 30-day option to purchase additional shares. However, the offering is subject to market conditions and uncertainties regarding its completion.
Price reaction · baseline $5.48 (2024-12-04T16:03:00.000Z) · hit during market hours · 1 other MYO headline(s) in the window, move may be shared
day 0 close · peak
-2.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Myomo is expanding its capital through a public offering.
  • The company aims to enhance its offerings for patients with neurological disorders.
  • The underwriter's option to purchase additional shares indicates confidence in demand.

CONCERNS & RISKS

  • The offering is subject to market conditions, introducing uncertainty.
  • There is no assurance on the completion or terms of the offering.

Full Press Release Details

BOSTON, December 4, 2024 – Myomo, Inc. (NYSE American: MYO) (“Myomo”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. In connection with the offering, Myomo also expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Read more .

Frequently Asked Questions

What is the purpose of Myomo's public offering?

The public offering aims to raise capital to enhance Myomo's offerings for patients with neurological disorders.

What is the size of the offering?

The exact size of the offering is not specified and is subject to market conditions.

What additional option does the underwriter have?

The underwriter has a 30-day option to purchase up to an additional 15% of the shares offered.

Is there any assurance on the offering's completion?

There is no assurance regarding the completion or terms of the offering.

Last updated: Dec 4, 2024